Search

everythinglearnresearchcommunity

for

Search:↓

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Severe genetic variants in children with a specific adrenal condition match predicted symptoms well, but milder variants do not.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Consider rare forms of CAH for accurate diagnosis and treatment.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Genetic mutations can affect female sexual development, requiring personalized medical care.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.